The treatment of hidradenitis suppurativa with the glucagon-like peptide-1 agonist liraglutide.

Jennings, L; Nestor, L; Molloy, O; Hughes, R; Moriarty, B; Kirby, B

Jennings, L; Nestor, L; Molloy, O; Hughes, R; Moriarty, B; Kirby, B.

Afiliación

Jennings L; Department of Dermatology, St Vincent's University Hospital, Dublin, Ireland.
Nestor L; Department of Dermatology, St Vincent's University Hospital, Dublin, Ireland.
Molloy O; Department of Dermatology, St Vincent's University Hospital, Dublin, Ireland.
Hughes R; Department of Dermatology, St Vincent's University Hospital, Dublin, Ireland.
Moriarty B; Department of Dermatology, St Vincent's University Hospital, Dublin, Ireland.
Kirby B; Department of Dermatology, St Vincent's University Hospital, Dublin, Ireland.

Br J Dermatol ; 177(3): 858-859, 2017 Sep.

Article en En | MEDLINE | ID: mdl-27943236

Asunto(s)

Hidradenitis Supurativa/tratamiento farmacológico; Hipoglucemiantes/uso terapéutico; Liraglutida/uso terapéutico; Adulto; Femenino; Humanos; Resultado del Tratamiento; Pérdida de Peso/efectos de los fármacos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hidradenitis Supurativa / Liraglutida / Hipoglucemiantes Límite: Adult / Female / Humans Idioma: En Revista: Br J Dermatol Año: 2017 Tipo del documento: Article País de afiliación: Irlanda

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google